SFX by Ex Libris Inc.

Title:	Gene Therapy for Severe Combined Immunodeficiency X1.
Source:	Blood [0006-4971] Hacein-Bey-Abina, S. yr:2005

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ginn, S. "Treatment of an infant with X-linked severe combined immunodeficiency (SCID-X1) by gene therapy in Australia." Medical journal of Australia 182.9 (2005): 458-63.
description	2.	Takahashi, A. "Radiation-induced apoptosis in SCID mouse spleen after low dose or low dose-rate irradiation." International journal of low radiation 1.2 (2004): 199-.
description	3.	Puck, Jennifer M. "Gene therapy for immune disorders: Good news tempered by bad news." The journal of allergy and clinical immunology 117.4 (2006): 865-9.
description	4.	Hacein-Bey-Abina, S. "A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency." New England Journal of Medicine, The 348.3 (2002): 255-6.
description	5.	Cavazzana-Calvo, M. "Gene therapy of severe combined immunodeficiencies." The journal of gene medicine 3.3 (2001): 201-206.
description	6.	Woods, Niels-Bjarne B. "Gene therapy: therapeutic gene causing lymphoma." Nature 440.7088: 1123-1123.
description	7.	Hacein-Bey-Abina, S. "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1." Science 302.5644 (2003): 415-9.
description	8.	Hacein-Bey-Abina, S. "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy." New England Journal of Medicine, The 346.16 (2002): 1185-1193.
description	9.	Gaspar, A J B. "Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency." Gene therapy 10.24 (2003): 1999-2004.
description	10.	Calvo, M. "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease." Science 288.5466 (2000): 669-672.
description	11.	Otsu, M. "Gene therapy in infants with severe combined immunodeficiency." BioDrugs 16.4: 229-239.
description	12.	Cavazzana-Calvo, M. "Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1." The journal of clinical investigation 118.9 (2008): 3132-42.
description	13.	White, K. "Novel vectors for in vivo gene delivery to vascular tissue." Expert Opinion on Biological Therapy 7.6 (2007): 809-821.
description	14.	Notarangelo, L. "Primary immunodeficiency diseases: an update." The journal of allergy and clinical immunology 114.3 (2004): 677-87.
description	15.	Williams, David A A. "Medicine. Gene therapy--new challenges ahead." Science 302.5644 (2003): 400-1.
description	16.	Fischer, A. "Severe combined immunodeficiency. A model disease for molecular immunology and therapy." Immunological reviews 203.1 (2005): 98-109.
description	17.	Devi, G. R. "siRNA-based approaches in cancer therapy." Cancer gene therapy 13.9 (2006): 819-29.
description	18.	Thrasher, Adrian J J. "Gene therapy: X-SCID transgene leukaemogenicity." Nature 443.7109: 5-6.
description	19.	Mendell, Jerry R R. "Risks, benefits, and consent in the age of gene therapy." Neurology 66.7 (2006): 964-5.
description	20.	Chinen, J. "Successes and risks of gene therapy in primary immunodeficiencies." The journal of allergy and clinical immunology 113.4 (2004): 595-603.